表紙
市場調査レポート

脊髄電気刺激装置:パイプライン分析

Spinal Cord Stimulators - Pipeline Review, 2015

発行 GlobalData 商品コード 345363
出版日 ページ情報 英文 107 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
脊髄電気刺激装置:パイプライン分析 Spinal Cord Stimulators - Pipeline Review, 2015
出版日: 2015年10月19日 ページ情報: 英文 107 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発が進められている脊髄電気刺激装置のパイプライン製品情報について分析しており、治験と製品開発の進行状況、段階別・セグメント別・国 (地域) 別の動向、企業と製品の詳細情報、最近の製品開発および業界の動向などの情報を盛り込んでいます。

第1章 目次

第2章 イントロダクション

  • 脊髄電気刺激装置の概要

第3章 開発中の製品

  • 脊髄電気刺激装置 - 開発段階別のパイプライン製品
  • 脊髄電気刺激装置 - 国 (地域) 別のパイプライン製品
  • 脊髄電気刺激装置 - 規制別のパイプライン製品
  • 脊髄電気刺激装置 - 認証時期別 (推定) のパイプライン製品
  • 脊髄電気刺激装置 - 現在進行中の治験

第4章 脊髄電気刺激装置 - 開発中のパイプライン製品:企業別

  • 脊髄電気刺激装置企業 - 開発段階別のパイプライン製品
  • 脊髄電気刺激装置 - 開発段階別のパイプライン製品

第5章 脊髄電気刺激装置企業と製品の概要

  • Boston Scientific Corporation
  • Direct Spinal Therapeutics, Inc.
  • Duke University
  • Imperial College London
  • Meagan Medical Inc.
  • Medtrode Inc.
  • Medtronic plc
  • MicroTransponder Inc.
  • NeuroRecovery Technologies Inc.
  • Nuvectra Corporation
  • Saluda Medical Pty Ltd
  • St. Jude Medical, Inc.
  • Stimwave Technologies, Inc.

第6章 脊髄電気刺激装置 - 最近の動向

第7章 付録

目次
Product Code: GDME0095EPD

GlobalData's Medical Devices sector report, "Spinal Cord Stimulators - Pipeline Review, 2015" provides an overview of Spinal Cord Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Spinal Cord Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Spinal Cord Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Spinal Cord Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Spinal Cord Stimulators Overview

3. Products under Development

  • 3.1. Spinal Cord Stimulators - Pipeline Products by Stage of Development
  • 3.2. Spinal Cord Stimulators - Pipeline Products by Territory
  • 3.3. Spinal Cord Stimulators - Pipeline Products by Regulatory Path
  • 3.4. Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
  • 3.5. Spinal Cord Stimulators - Ongoing Clinical Trials

4. Spinal Cord Stimulators - Pipeline Products under Development by Companies

  • 4.1. Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development
  • 4.2. Spinal Cord Stimulators - Pipeline Products by Stage of Development

5. Spinal Cord Stimulators Companies and Product Overview

  • 5.1. Boston Scientific Corporation Company Overview
    • 5.1.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Direct Spinal Therapeutics, Inc. Company Overview
    • 5.2.1. Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Duke University Company Overview
    • 5.3.1. Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Imperial College London Company Overview
    • 5.4.1. Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Meagan Medical Inc. Company Overview
    • 5.5.1. Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Medtrode Inc. Company Overview
    • 5.6.1. Medtrode Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Medtronic plc Company Overview
    • 5.7.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. MicroTransponder Inc. Company Overview
    • 5.8.1. MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. NeuroRecovery Technologies Inc. Company Overview
    • 5.9.1. NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Nuvectra Corporation Company Overview
    • 5.10.1. Nuvectra Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Saluda Medical Pty Ltd Company Overview
    • 5.11.1. Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. St. Jude Medical, Inc. Company Overview
    • 5.12.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Stimwave Technologies, Inc. Company Overview
    • 5.13.1. Stimwave Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Spinal Cord Stimulators- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development
  • Table 2: Spinal Cord Stimulators - Pipeline Products by Territory
  • Table 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path
  • Table 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
  • Table 5: Spinal Cord Stimulators - Ongoing Clinical Trials
  • Table 6: Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development
  • Table 7: Spinal Cord Stimulators - Pipeline Products by Stage of Development
  • Table 8: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Precision Implantable Neurostimulator - Migraine - Product Status
  • Table 10: Precision Implantable Neurostimulator - Migraine - Product Description
  • Table 11: Boston Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 12: Precision Implantable Neurostimulator - Migraine - Occipital Nerve Stimulation (ONS) for Migraine OPTIMISE
  • Table 13: Precision Implantable Neurostimulator - Migraine - Two-years Follow-up of Post-spinal Implantable Neurostimulator PRECISION
  • Table 14: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Iowa-Patch System - Product Status
  • Table 16: Iowa-Patch System - Product Description
  • Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Spinal Cord Stimulator - Product Status
  • Table 19: Spinal Cord Stimulator - Product Description
  • Table 20: Duke University - Ongoing Clinical Trials Overview
  • Table 21: Spinal Cord Stimulator - Pain Coping Skills Training for Spinal Cord Stimulator Implant Candidates
  • Table 22: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Wireless Intraspinal Microstimulation System - Product Status
  • Table 24: Wireless Intraspinal Microstimulation System - Product Description
  • Table 25: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: DISCSS IFC System - Product Status
  • Table 27: DISCSS IFC System - Product Description
  • Table 28: Medtrode Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Implantable Pulse Generator - Product Status
  • Table 30: Implantable Pulse Generator - Product Description
  • Table 31: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Intellis RC - Product Status
  • Table 33: Intellis RC - Product Description
  • Table 34: MRI Surgical Lead - Product Status
  • Table 35: MRI Surgical Lead - Product Description
  • Table 36: PNS Device - Chronic Back Pain - Product Status
  • Table 37: PNS Device - Chronic Back Pain - Product Description
  • Table 38: PrimeADVANCED - Heart Failure - Product Status
  • Table 39: PrimeADVANCED - Heart Failure - Product Description
  • Table 40: Medtronic plc - Ongoing Clinical Trials Overview
  • Table 41: PrimeADVANCED - Heart Failure - Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure
  • Table 42: PNS Device - Chronic Back Pain - Interventional, Prospective, Multi-Center, Randomized, Parallel-arm Study to Compare the Effectiveness of Peripheral Nerve Stimulation (PNS) Utilizing a Subcutaneous Lead Implant Technique (SQS) Plus Optimized Medical Management (OMM) Versus OMM Alone in Patients Suffering From Back Pain Due to Failed Back Surgery Syndrome (FBSS)
  • Table 43: MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: SAINT System - Chronic Pain - Product Status
  • Table 45: SAINT System - Chronic Pain - Product Description
  • Table 46: NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: External Spinal Cord Neuromodulation System - Product Status
  • Table 48: External Spinal Cord Neuromodulation System - Product Description
  • Table 49: Spinal Cord Stimulation Device - Product Status
  • Table 50: Spinal Cord Stimulation Device - Product Description
  • Table 51: Nuvectra Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Algovita System - Product Status
  • Table 53: Algovita System - Product Description
  • Table 54: Nuvectra Corporation - Ongoing Clinical Trials Overview
  • Table 55: Algovita System - Real-world Evaluation of Outcome Data Under a Prospective, Observational, Post-Market Clinical Study, Using the Algovita SCS System to Treat Patients With Chronic Pain of the Trunk and/or Limbs Per the Applicable Indications for Use
  • Table 56: Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Evoke Spinal Cord Stimulation System - Product Status
  • Table 58: Evoke Spinal Cord Stimulation System - Product Description
  • Table 59: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Axium Spinal Cord Stimulation System - Product Status
  • Table 61: Axium Spinal Cord Stimulation System - Product Description
  • Table 62: Next Generation Implantable SCS System - Primary Cell - Product Status
  • Table 63: Next Generation Implantable SCS System - Primary Cell - Product Description
  • Table 64: Next Generation Implantable SCS System - Rechargeable - Product Status
  • Table 65: Next Generation Implantable SCS System - Rechargeable - Product Description
  • Table 66: Proclaim DRG - Product Status
  • Table 67: Proclaim DRG - Product Description
  • Table 68: Proclaim Rechargeable Model - Product Status
  • Table 69: Proclaim Rechargeable Model - Product Description
  • Table 70: Proclaim SCS - Product Status
  • Table 71: Proclaim SCS - Product Description
  • Table 72: Proclaim Upgrade HC - Product Status
  • Table 73: Proclaim Upgrade HC - Product Description
  • Table 74: Proclaim Upgrade LC - Product Status
  • Table 75: Proclaim Upgrade LC - Product Description
  • Table 76: Prodigy SCS System - Product Status
  • Table 77: Prodigy SCS System - Product Description
  • Table 78: St. Jude Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 79: Axium Spinal Cord Stimulation System - A BavariAn Evaluation of DRG Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin
  • Table 80: Axium Spinal Cord Stimulation System - A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Intractable Pain
  • Table 81: Axium Spinal Cord Stimulation System - A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg
  • Table 82: Axium Spinal Cord Stimulation System - A Post Market Cohort with the Commercially Available Spinal Modulation Neurostimulator System for the Management of Peripheral Neuropathy
  • Table 83: Axium Spinal Cord Stimulation System - A Post Market Observational Cohort Study to Assess the Performance of the Spinal Modulation Dorsal Root Ganglion Stimulator System for the Management of Chronic Post Surgical Pain
  • Table 84: Axium Spinal Cord Stimulation System - A Post Market Observational Study on the Effect of DRG Stimulation in Patients with Chronic Pain Following Surgical Lumbar Discectomy (Failed Back Surgery Syndrome): SYMPATHY
  • Table 85: Axium Spinal Cord Stimulation System - A Prospective Post Market Trial of DRG stiImulation with the Commercially Available Axium
  • Table 86: Axium Spinal Cord Stimulation System - A Prospective, Randomized, Multi-center, Controlled Clinical Trial to Assess the Safety and Efficacy of the Spinal Modulation AXIUM Neurostimulator System in the Treatment of Chronic Pain (ACCURATE Trial)
  • Table 87: Axium Spinal Cord Stimulation System - A Randomised Pilot Study to Assess Differences in the Subjects' Experience of Stimulation-induced Paraesthesia Between Two Different Spinal Cord Stimulation Devices: The Axium Dorsal Root Ganglion Stimulation System versus the Prime Advanced Dorsal Column Stimulation System (CHARACTER SCS)
  • Table 88: Axium Spinal Cord Stimulation System - A Randomized Controlled Trial to Evaluate the Efficacy of the Spinal Modulation Axium Neurostimulator Therapy as a Treatment for Persistent Inguinal Pain Following Surgical Intervention
  • Table 89: Axium Spinal Cord Stimulation System - BINGO: A Post Market Evaluation of Chronic intractable Pain and the Efficacy of DRG stimulation in the Nordic Region
  • Table 90: Axium Spinal Cord Stimulation System - Clinical Study Protocol Dorsal Root Ganglion Stimulation for the Management of Painful Intractable Small Fibre Neuropathy
  • Table 91: Prodigy SCS System - A Post-market Study Evaluating the Prodigy Neuromodulation System for the Management of Failed Back Surgery Syndrome or Chronic Intractable Pain of the Trunk and/or Limbs
  • Table 92: Prodigy SCS System - Success Using Neuromodulation with BURST (SUNBURST) Study
  • Table 93: Stimwave Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Freedom-8 SCS System - Product Status
  • Table 95: Freedom-8 SCS System - Product Description
  • Table 96: Stimwave Technologies, Inc. - Ongoing Clinical Trials Overview
  • Table 97: Freedom-8 SCS System - Stimwave Freedom Eight-electrode, Multi-programmable Wireless Miniature Injectable Stimulator for Relief of Chronic Back and Leg Pain
  • Table 98: Glossary

List of Figures

  • Figure 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development
  • Figure 2: Spinal Cord Stimulators - Pipeline Products by Territory
  • Figure 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path
  • Figure 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
  • Figure 5: Spinal Cord Stimulators - Ongoing Clinical Trials
Back to Top